Volume 31, Issue 4 p. 452
Letter to the Editor

Letter to the Editor Re: Balancing diagnostic advancements with cardiovascular considerations in 5-aminolevulinic acid use for bladder tumors

Fumihiko Urabe MD, PhD

Corresponding Author

Fumihiko Urabe MD, PhD

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
Kagenori Ito MD, PhD

Kagenori Ito MD, PhD

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
Takahiro Kimura MD, PhD

Takahiro Kimura MD, PhD

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
First published: 20 December 2023
No abstract is available for this article.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.